This effect persisted even after adjusting for potential confounding factors.
non ATT treated patients. It is unclear whether this effect reflects the intrinsic underlying severity of disease (i.e. study bias), or whether steroid sparing immmunosuppresive agents mitigate against successful ATT therapy.
Introduction
Tuberculosis (TB) remains a major global health problem with an estimated 8.6 million people who have developed TB and 1.3 million deaths in 2012. [1] Among the developed western countries, the UK has one of the highest incidence rates of 13.9/100,000 reported in 2012. The risk factors include young age, male gender and being born outside of the UK. Increased and rising rates are seen in the population from the Indian subcontinent and in those who have been resident in the UK for long periods of time prior to their TB diagnosis. [2] The clinical diagnosis of ocular TB is difficult since clinical signs and symptoms can mimic other conditions. [3 4 ] The ophthalmologist relies on a combination of clinical history, ocular signs, systemic examination by a physician, and screening investigations such as chest radiographs and the tuberculin skin test (TST). [3 4] A definite diagnosis of TB uveitis can be confirmed by performing acid-fast smears, mycobacterial cultures, or polymerase chain reaction-based assays on ocular fluid samples. Limited, Carnegie, Victoria, Australia). [7] We examined the predictive failure related to treatment failure or success in a TB-non endemic, cosmopolitan population.
Methods
This was a retrospective review of health records of patients seen at a large tertiary uveitic centre in central London, UK. The study was approved by the institutional review board (ROAD 14/012) and all the research adhered to the tenets of the Helsinki declaration. We further compared the cohort of patients who received steroid sparing immunosuppressive agents with the group who did not have ( Table 4) 
